🇺🇸 FDA
Pipeline program

Healive® Lot 1

PRO-HA-4006

Approved mab completed

Quick answer

Healive® Lot 1 for Hepatitis A is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Hepatitis A
Phase
Approved
Modality
mab
Status
completed

Clinical trials